Literature DB >> 24983016

Estimating the true prevalence of hepatitis C in rhode island.

Elizabeth N Kinnard1, Lynn E Taylor2, Omar Galárraga3, Brandon D L Marshall4.   

Abstract

Although there is a large health, social, and economic burden of hepatitis C virus (HCV) infection in the United States, the number of persons infected with HCV in Rhode Island (RI) is unknown. To inform the expansion of HCV-related public health efforts in RI, and because surveillance data are lacking and national surveys, including the National Health and Nutrition Examination Survey (NHANES), likely underestimate true HCV prevalence, we reviewed published peer-reviewed and grey literature to more accurately estimate the prevalence of HCV in RI. The results of our review suggest that between 16,603 and 22,660 (1.7%-2.3%) persons in RI have ever been infected with HCV. Assuming a spontaneous clearance rate of 26%, we estimate that between 12,286 and 16,768 (1.2%-1.7%) have ever been or are currently chronically infected with HCV. Findings suggest the urgent need for improved HCV screening in RI, and that reducing morbidity and mortality from HCV will require a dramatic scale-up of testing, linkage to care, treatment and cure.

Entities:  

Keywords:  HCV; Hepatitis C; Rhode Island; epidemiology; prevalence

Mesh:

Year:  2014        PMID: 24983016      PMCID: PMC4349508     

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  47 in total

1.  Hepatitis C virus infection among firefighters, emergency medical technicians, and paramedics--selected locations, United States, 1991-2000.

Authors:  A J Roome; J L Hadler; A L Thomas; B Migicovsky; R Roth; M Boraz; B Kuszajewksi; D Berkowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-07-28       Impact factor: 17.586

2.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

Authors:  Lisa I Backus; Derek B Boothroyd; Barbara R Phillips; Pamela Belperio; James Halloran; Larry A Mole
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

4.  Viral hepatitis and other infectious diseases in a homeless population.

Authors:  Ramsey C Cheung; Aspasia K Hanson; Kalyani Maganti; Emmet B Keeffe; Suzanne M Matsui
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

Review 5.  Hepatitis C virus infection in USA: an estimate of true prevalence.

Authors:  Eric Chak; Andrew H Talal; Kenneth E Sherman; Eugene R Schiff; Sammy Saab
Journal:  Liver Int       Date:  2011-03-16       Impact factor: 5.828

6.  Seroprevalence of viral hepatitis in an older nursing home population.

Authors:  N T Chien; G Dundoo; M H Horani; P Osmack; J H Morley; A M Di Bisceglie
Journal:  J Am Geriatr Soc       Date:  1999-09       Impact factor: 5.562

7.  Prevalence of Hepatitis C virus infection in a sample of homeless veterans.

Authors:  Rani A Desai; Robert A Rosenheck; Vincent Agnello
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2003-07       Impact factor: 4.328

8.  Outcome of screening for hepatitis C virus infection based on risk factors.

Authors:  Carol Mallette; Maura A Flynn; Kittichai Promrat
Journal:  Am J Gastroenterol       Date:  2007-09-25       Impact factor: 10.864

9.  Blood exposures and hepatitis C virus infections among emergency responders.

Authors:  S Deblina Datta; Gregory L Armstrong; Aaron J Roome; Miriam J Alter
Journal:  Arch Intern Med       Date:  2003-11-24

10.  The natural history of hepatitis C virus (HCV) infection.

Authors:  Stephen L Chen; Timothy R Morgan
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

View more
  4 in total

1.  Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination.

Authors:  A I Soipe; H Razavi; D Razavi-Shearer; O Galárraga; L E Taylor; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-08-05       Impact factor: 2.451

2.  Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program.

Authors:  Jackie Habchi; Aurielle M Thomas; Sophie Sprecht-Walsh; Elenita Arias; Jeffrey Bratberg; Linda Hurley; Susan Hart; Lynn E Taylor
Journal:  Open Forum Infect Dis       Date:  2020-10-13       Impact factor: 3.835

3.  Prevalence of Hepatitis C infection in Qeshm Island in 2013-2014, Iran.

Authors:  I Ghasemzadeh; A Alavi-Nasr; M Khademi; A Kargar Kheirabad; H Gouklani
Journal:  J Med Life       Date:  2015

4.  Estimating the prevalence of chronic hepatitis C virus infection in New York City, 2015.

Authors:  A Bocour; S K Greene; F Laraque; A Winters
Journal:  Epidemiol Infect       Date:  2018-06-22       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.